Cargando…
Azvudine (FNC): a promising clinical candidate for COVID-19 treatment
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547293/ https://www.ncbi.nlm.nih.gov/pubmed/33040075 http://dx.doi.org/10.1038/s41392-020-00351-z |
| _version_ | 1783592388103503872 |
|---|---|
| author | Yu, Bin Chang, Junbiao |
| author_facet | Yu, Bin Chang, Junbiao |
| author_sort | Yu, Bin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7547293 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75472932020-10-14 Azvudine (FNC): a promising clinical candidate for COVID-19 treatment Yu, Bin Chang, Junbiao Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2020-10-10 /pmc/articles/PMC7547293/ /pubmed/33040075 http://dx.doi.org/10.1038/s41392-020-00351-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Highlight Yu, Bin Chang, Junbiao Azvudine (FNC): a promising clinical candidate for COVID-19 treatment |
| title | Azvudine (FNC): a promising clinical candidate for COVID-19 treatment |
| title_full | Azvudine (FNC): a promising clinical candidate for COVID-19 treatment |
| title_fullStr | Azvudine (FNC): a promising clinical candidate for COVID-19 treatment |
| title_full_unstemmed | Azvudine (FNC): a promising clinical candidate for COVID-19 treatment |
| title_short | Azvudine (FNC): a promising clinical candidate for COVID-19 treatment |
| title_sort | azvudine (fnc): a promising clinical candidate for covid-19 treatment |
| topic | Research Highlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547293/ https://www.ncbi.nlm.nih.gov/pubmed/33040075 http://dx.doi.org/10.1038/s41392-020-00351-z |
| work_keys_str_mv | AT yubin azvudinefncapromisingclinicalcandidateforcovid19treatment AT changjunbiao azvudinefncapromisingclinicalcandidateforcovid19treatment |